Unique ID issued by UMIN | UMIN000033376 |
---|---|
Receipt number | R000038036 |
Scientific Title | Observational Multicenter Study of Relationship between Peripheral Neuropathy and Effectiveness in 2nd Line Therapy for Unresectable Advanced Gastric Cancer |
Date of disclosure of the study information | 2018/09/15 |
Last modified on | 2020/07/13 15:49:26 |
Observational Multicenter Study of Relationship between Peripheral Neuropathy and Effectiveness in 2nd Line Therapy for Unresectable Advanced Gastric Cancer
IVY Study
Observational Multicenter Study of Relationship between Peripheral Neuropathy and Effectiveness in 2nd Line Therapy for Unresectable Advanced Gastric Cancer
IVY Study
Japan |
Gastric Cancer
Gastroenterology |
Malignancy
NO
Examination of relationship between peripheral neuropathy and effectiveness in 2nd line therapy for unresectable advanced gastric cancer
Safety,Efficacy
relationship between frequency of peripheral neuropathy and effectiveness of chemotherapy
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)This is a case of unresectable or recurrent gastric cancer histologically confirmed to be the primary adenocarcinoma of the stomach.
2)Patient's age is over than 20 years old
3)Cases with Performance Status (PS) of 0-2 in ECOG
4)Patients who have been fully informed of this study and have given written informed consent
5)Patients resisted first line chemotherapy consisted of fluorinated pyrimidine anticancer drugs (e.g., 5-FU, S-1, capecitabine, UFT) and platinum anticancer drugs (cisplatin or oxaliplatin) for unresectable or recurrent gastric cancer.
1)Patient's prognosis is within three months
2)With severe complications (angina pectoris, myocardial infarction and arrhythmia) and uncontrollable DM, blood hypertension and bleeding tendency
3)History of serious allergic reaction and with serious drug allergy
4)With clinically relevant mental disorder to be unable to answer questionnaires
5)Patients for whom the attending physician considered enrollment in the study inappropriate
200
1st name | Hiroaki |
Middle name | |
Last name | Tanioka |
Kawasaki Medical School
Department of Clinical Oncology
7010192
577 Matsushima, Kurashiki City Okayama 701-0192, Japan
0864621111
tanioka@med.kawasaki-m.ac.jp
1st name | Hiroaki |
Middle name | |
Last name | Tanioka |
Kawasaki Medical School
Department of Clinical Oncology
7010192
577 Matsushima, Kurashiki City Okayama 701-0192, Japan
0864621111
tanioka@med.kawasaki-m.ac.jp
Kawasaki Medical School
Kawasaki Medical School
Self funding
Kawasaki Medical School
577 Matsushima, Kurashiki City Okayama 701-0192, Japan
0864621111
kmsrec@med.kawasaki-m.ac.jp
NO
2018 | Year | 09 | Month | 15 | Day |
Unpublished
Open public recruiting
2018 | Year | 08 | Month | 01 | Day |
2018 | Year | 09 | Month | 10 | Day |
2018 | Year | 09 | Month | 01 | Day |
2022 | Year | 10 | Month | 31 | Day |
none
2018 | Year | 07 | Month | 12 | Day |
2020 | Year | 07 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038036
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |